Cytonics Corporation Revenue and Competitors

Cytonics is a research and development company dedicated to discovering and developing therapeutics based on the protease inhibitor Alpha2 Macroglobulin (A2M). We are developing a number of A2M therapies with the goal of out-licensing the drugs to strategic partners at the key clinical value inflection points. We maximize the value of the drugs we discover by putting them in the hands of leading pharmaceutical companies with late-stage development, commercialization and marketing expertise. As a result of this strategy, we keep our organization focused with a strong financial position. We have discovered a unique “bio-marker” that can assist physicians in improving patient outcomes by pinpointing the source of orthopedic pain. We are also developing a range of therapeutic products for the treatment of painful osteoarthritis, back, and joint pain. Cytonics has a research lab located in Jupiter, FL with a team of scientists and PhD’s, working to discover and develop products for the treatment of musculoskeletal disease. Our Mission is to be the leader in diagnostic products for musculoskeletal disease, and to develop highly effective biotechnology based treatments for back and joint pain.